A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)
Public ClinicalTrials.gov record NCT03679767. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of INCMGA00012 (PD-1 Inhibitor) in Participants With Selected Solid Tumors (POD1UM-203)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the clinical activity and safety of INCMGA00012 in participants with advanced solid tumors where the efficacy of PD-1 inhibitors has previously been established.
Study identification
- NCT ID
- NCT03679767
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 121 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 9, 2019 (Actual)
- Primary completion
- Apr 15, 2021 (Actual)
- Completion
- Jun 28, 2022 (Actual)
- Last update posted
- Jul 21, 2023
2019 – 2022
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Cancer Associates for Research and Excellence, Inc. | Fresno | California | 93720 | — |
| California Cancer Associates for Research and Excellence | Fresno | California | 93720 | — |
| California Cancer Associates for Research and Excellence, Inc. | San Marcos | California | 92069 | — |
| St Joseph Heritage Healthcare | Santa Rosa | California | 95403 | — |
| St. Joseph Health Medical Group - Annadel Medical Group | Santa Rosa | California | 95403 | — |
| Rocky Mountain Cancer Centers - Denver - Midtown | Denver | Colorado | 80218 | — |
| Christiana Care Helen F. Graham Cancer Center | Newark | Delaware | 19718 | — |
| Rcca Md, Llc | Bethesda | Maryland | 20817 | — |
| VA New Jersey Health Care System | East Orange | New Jersey | 07018 | — |
| New York Oncology Hematology - Albany | Albany | New York | 12208 | — |
| Kaiser Permanente | Portland | Oregon | 97227 | — |
| Texas Oncology Surgical Specialists - Austin Central | Austin | Texas | 78731 | — |
| Coastal Bend Cancer Center | Corpus Christi | Texas | 78404 | — |
| AIM Trials, LLC | Plano | Texas | 75093 | — |
| Texas Oncology - San Antonio Northeast | San Antonio | Texas | 78217 | — |
| Oncology and Hematology Associates of Southwest Virginia, Inc. | The Woodlands | Texas | 77380 | — |
| Texas Oncology - Waco | Waco | Texas | 76712 | — |
| Oncology & Hematology Associates of Southwest Virginia, Inc. | Wytheville | Virginia | 24382 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03679767, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 21, 2023 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03679767 live on ClinicalTrials.gov.